Notices

• Medicare Program; Prior Authorization of Non-Emergent Hyperbaric Oxygen (HBO) Therapy

  

• Medicare Program; Prior Authorization of Repetitive Scheduled Nonemergent Ambulance Transports

  

• Medicare and Medicaid Programs; Quarterly Listing of Program Issuances-July Through September 2014

  

• Medicare Program; Administrative Law Judge Hearing Program for Medicare Claim Appeals

  

• Medicare Program; Appellant Forum Regarding the Administrative Law Judge Hearing Program for Medicare Claim Appeals

  

• Medicare Program; The Advisory Panel on Hospital Outpatient Payment (HOP Panel) Spring Meeting, March 9-10, 2015

  

• Medicare Program; Medicare Part B Monthly Actuarial Rates, Premium Rate, and Annual Deductible Beginning January 1, 2015

  

• Medicare Program; CY 2015 Inpatient Hospital Deductible and Hospital and Extended Care Services Coinsurance Amounts

  

• Medicare Program; CY 2015 Part A Premiums for the Uninsured Aged and for Certain Disabled Individuals Who Have Exhausted Other Entitlement

  

• Medicare Program; Medicare Appeals; Adjustment to the Amount in Controversy Threshold Amounts for Calendar Year 2015

  

• Medicare and Medicaid Programs Renewal of Deeming Authority of the Accreditation Association for National Committee for Quality Assurance (NCQA)

  

• Medicare Program; Evaluation Criteria and Standards for Quality Improvement Networks Quality Improvement Program Contracts [Base and Task Order(s)]

  

• Medicare Program; Expanded Medicare Prior Authorization for Power Mobility Devices (PMDs) Demonstration

  

• Medicare and Medicaid Programs; Quarterly Listing of Program Issuances-April Through June 2014

  

• Availability of Interpretive Rule: Implementation of the Exclusion of Orphan Drugs for Certain Covered Entities Under the 340B Program

  

• Proposed Data Collections Submitted for Public Comment and Recommendations

  

• Office of the National Coordinator for Health Information Technology; Announcement of Requirements and Registration for “EHR Innovations for Improving Hypertension Challenge”

  

• Bulk Drug Substances That May Be Used To Compound Drug Products in Accordance With Section 503B of the Federal Food, Drug, and Cosmetic Act, Concerning Outsourcing Facilities; Revised Request for Nominations

  

• Bulk Drug Substances That May Be Used To Compound Drug Products in Accordance With Section 503A of the Federal Food, Drug, and Cosmetic Act; Revised Request for Nominations

  

• Global Unique Device Identification Database; Guidance for Industry and Food and Drug Administration Staff; Availability